type 2 diabetes

No evidence of benefit for insulin analogs over nph insulin

No evidence of benefit for insulin analogs over nph insulin

Tujeo and Tresiba are two new long-acting insulin analogs that can be prescribed to patients with type 1 and type 2 diabetes to maintain normal blood glucose levels between meals and at night. Patients with type 1 diabetes should combine this type of insulin with the insulin recommended for administration at meals – most often …

No evidence of benefit for insulin analogs over nph insulin Read More »

effectiveness of peer support in type 2 diabetes

More evidence needed on the cost effectiveness of peer support in type 2 diabetes

The modern world offers our society a global acceleration of life. Day after day passes, people build a career, live an active social life, and periodically struggle with emerging problems and diseases. In this rhythm, it is impossible not to pay attention to the fact that the younger generation often remains left to themselves. Of …

More evidence needed on the cost effectiveness of peer support in type 2 diabetes Read More »

Metformin

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes

Effectiveness and features of Metformin administration in diabetes mellitus OUR READERS RECOMMEND! . Seeing the popularity of this tool, we decided to offer it to your attention. Metformin is a vital drug for people with diabetes. The drug has a glucose-lowering effect that regulates blood sugar levels, reduces appetite and promotes active fat burning. The …

Metformin may be associated with a reduced risk of liver cancer in type 2 diabetes Read More »

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy

Metformin is widely used as a first line treatment for type 2 diabetes and it is usually continued when treatment is intensified, such as with other oral agents or by insulin therapy. This systematic review looked at whether metformin is actually beneficial to patients who are using insulin. Clinical question: In people with type 2 …

Lack of clear evidence for metformin in type 2 diabetes on insulin therapy Read More »

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes

General information: what is glycemia in diabetes Type 2 diabetes is characterized by a constant deterioration of beta cell function, so treatment should be dynamic, involving a gradual increase in drug intervention as the disease progresses.Ideally, the blood glucose level should be maintained within the limits close to normal: before meals, blood glucose is 5-7 …

Insufficient evidence of benefit for colesevelam in glycemic control in type 2 diabetes Read More »